MAP1LC3A Primary Antibody

Item Information
Catalog # Size/Concentration Price
31712 100ug $341.00
Specification
AliasesLC3; LC3A; ATG8E; MAP1ALC3; MAP1BLC3
Clone#7E9E12
Entrez GeneID84557
FormulationPurified antibody in PBS with 0.05% sodium azide
HostMouse
IsotypeIgG1
ImmunogenMouse IgG1
MW50.9kDa
Application
ELISA1/10000
FCM (Flow Cytometry)1/200 - 1/400
Sequence
(AA: 1-121) expressed in E. Coli.
Catalog
31712
$341.00
-
+

Contact us to order

Images

Figure 1: Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)

Cell Culture Products

Figure 2: Western blot analysis using MAP1LC3A mAb against human MAP1LC3A (AA: 1-121) recombinant protein. (Expected MW is 39.7 kDa)

Cell Culture Products

Figure 3: Western blot analysis using MAP1LC3A mAb against HEK293 (1) and MAP1LC3A (AA: 1-121)-hIgGFc transfected HEK293 (2) cell lysate.

Cell Culture Products

Figure 4: Flow cytometric analysis of Hela cells using MAP1LC3A mouse mAb (green) and negative control (red).

Cell Culture Products
Tissue Array Results
Position Tissues Name Result Localization
Nucleus Cytoplasm Membrane
E9/10 Endometrial Cancer
View Full Documents
Product Overview
Description

MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. The protein encoded by this gene is one of the light chain subunits and can associate with either MAP1A or MAP1B. Two transcript variants encoding different isoforms have been found for this gene. The expression of variant 1 is suppressed in many tumor cell lines, suggesting that may be involved in carcinogenesis. [provided by RefSeq, Feb 2012]

References (references)
References (references) 1.J Cancer Res Clin Oncol. 2018 Jun;144(6):1037-1047.
2.J Exp Clin Cancer Res. 2014 Apr 10;33:32.

Please view FAQs here